INTO ACCELERATING INHALATION DEVELOPMENT
LIVE

Serial Number

79363031

Owner

DFE PHARMA GMBH & CO. KG

Attorney

Michael N. Mercanti

Filing Date

Nov 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

INTO ACCELERATING INHALATION DEVELOPMENT Trademark

Serial Number: 79363031 • Registration: 7416390

INTO ACCELERATING INHALATION DEVELOPMENT is a trademark filed by DFE PHARMA GMBH & CO. KG on November 21, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

DFE PHARMA GMBH & CO. KG (16 trademarks)

KLEVER STRASSE 187
GOCH 47574 , DE

Entity Type: 28

STERLING S.P.A.

VIA DELLA CARBONERIA 30

Entity Type: 99

Harro Höfliger Verpackungsmaschinen GmbH (5 trademarks)

Helmholtzstr. 4

Entity Type: 99

Trademark Details

Filing Date

November 21, 2022

Registration Date

June 18, 2024

Published for Opposition

April 2, 2024

Goods & Services

Pharmaceutical and chemical research services; pharmaceutical and chemical product development services for others; pharmaceutical and chemical design services being pharmaceutical and chemical product development services for others; testing of pharmaceuticals and chemicals; medical and scientific research, namely, conducting clinical trials of pharmaceuticals for others and testing of chemicals; pharmaceutical and chemical analysis; laboratory research services relating to orally inhaled and nasal drugs products; pharmaceutical and chemical product evaluation; preparation of reports in the nature of technical writing relating to the aforesaid pharmaceutical and chemical research; inspection being testing and inspection of pharmaceuticals and chemicals; scientific and technological services, namely, scientific research, formulation development, analysis and testing in the field of orally inhaled and nasal drugs products; biological research services; quality control for others and authentication services for pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services

Pharmaceuticals, pharmaceutical preparations, pharmaceuticals for medical or veterinary purposes, pharmaceutical compositions, vaccines and medicine being pharmaceutical preparations, all for use in the treatment of respiratory diseases

Chemicals, chemical additives and chemical compositions, namely, active chemical ingredients and excipients for use in the manufacture of pharmaceuticals for treating respiratory diseases; chemical substances for analyses in laboratories, other than for medical or veterinary purposes, and use in the manufacture of pharmaceuticals

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 2, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2025 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 27, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 27, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 16, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 23, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 23, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 23, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 27, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 11, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 10, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 22, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 16, 2023 REPR